10x Genomics, Inc. Operating Income
10x Genomics, Inc. (TXG) reported Operating Income of -$19.55 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-07
- 10x Genomics, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$19.55M, a 164.91% decline year-over-year.
- 10x Genomics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$17.05M.
- 10x Genomics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$19.54M.
- 10x Genomics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$32.24M.
- 10x Genomics, Inc. operating income (loss) for fiscal 2025 was -$60.98M.
- 10x Genomics, Inc. operating income (loss) for fiscal 2024 was -$194.56M.
- 10x Genomics, Inc. operating income (loss) for fiscal 2023 was -$265.33M.
- 10x Genomics, Inc. operating income (loss) for fiscal 2022 was -$167.94M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$19.55M 10-Q · filed 2026-08-07 | -$36.60M 10-Q · filed 2026-08-07 | -$56.14M derived: sum of 3 quarters · filed 2026-08-07 | -$88.38M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$17.05M 10-Q · filed 2026-05-08 | -$36.59M derived: sum of 2 quarters · filed 2026-05-08 | -$68.83M derived: sum of 3 quarters · filed 2026-05-08 | -$38.70M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$19.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$51.78M derived: sum of 2 quarters · filed 2026-02-13 | -$21.66M derived: sum of 3 quarters · filed 2026-08-07 | -$60.98M 10-K · filed 2026-02-13 |
| 2025-09-30 | -$32.24M 10-Q · filed 2025-11-07 | -$2.12M derived: sum of 2 quarters · filed 2026-08-07 | -$41.44M 10-Q · filed 2025-11-07 | -$91.28M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $30.13M 10-Q · filed 2026-08-07 | -$9.20M 10-Q · filed 2026-08-07 | -$59.04M derived: sum of 3 quarters · filed 2026-08-07 | -$100.53M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$39.33M 10-Q · filed 2026-05-08 | -$89.17M derived: sum of 2 quarters · filed 2026-05-08 | -$130.65M derived: sum of 3 quarters · filed 2026-05-08 | -$172.39M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$49.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$91.32M derived: sum of 2 quarters · filed 2026-02-13 | -$133.06M derived: sum of 3 quarters · filed 2026-02-13 | -$194.56M 10-K · filed 2026-02-13 |
| 2024-09-30 | -$41.48M 10-Q · filed 2025-11-07 | -$83.22M derived: sum of 2 quarters · filed 2025-11-07 | -$144.72M 10-Q · filed 2025-11-07 | -$199.91M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | -$41.74M 10-Q · filed 2025-08-08 | -$103.23M 10-Q · filed 2025-08-08 | -$158.42M derived: sum of 3 quarters · filed 2026-02-13 | -$253.22M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | -$61.50M 10-Q · filed 2025-05-09 | -$116.69M derived: sum of 2 quarters · filed 2026-02-13 | -$211.48M derived: sum of 3 quarters · filed 2026-02-13 | -$274.84M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | -$55.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$149.98M derived: sum of 2 quarters · filed 2026-02-13 | -$213.34M derived: sum of 3 quarters · filed 2026-02-13 | -$265.33M 10-K · filed 2026-02-13 |
| 2023-09-30 | -$94.80M 10-Q · filed 2024-10-29 | -$158.15M derived: sum of 2 quarters · filed 2024-10-29 | -$210.14M 10-Q · filed 2024-10-29 | -$233.24M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | -$63.36M 10-Q · filed 2024-08-08 | -$115.35M 10-Q · filed 2024-08-08 | -$138.44M derived: sum of 3 quarters · filed 2025-02-13 | -$178.44M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | -$51.99M 10-Q · filed 2024-04-30 | -$75.08M derived: sum of 2 quarters · filed 2025-02-13 | -$115.08M derived: sum of 3 quarters · filed 2025-02-13 | -$178.20M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | -$23.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$63.09M derived: sum of 2 quarters · filed 2025-02-13 | -$126.21M derived: sum of 3 quarters · filed 2025-02-13 | -$167.94M 10-K · filed 2025-02-13 |
| 2022-09-30 | -$40.00M 10-Q · filed 2023-11-03 | -$103.11M derived: sum of 2 quarters · filed 2023-11-03 | -$144.85M 10-Q · filed 2023-11-03 | -$160.68M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | -$63.12M 10-Q · filed 2023-08-04 | -$104.85M 10-Q · filed 2023-08-04 | -$120.68M derived: sum of 3 quarters · filed 2024-02-15 | -$136.56M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | -$41.73M 10-Q · filed 2023-05-04 | -$57.56M derived: sum of 2 quarters · filed 2024-02-15 | -$73.44M derived: sum of 3 quarters · filed 2024-02-15 | -$83.77M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | -$15.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$31.71M derived: sum of 2 quarters · filed 2024-02-15 | -$42.04M derived: sum of 3 quarters · filed 2024-02-15 | -$52.25M 10-K · filed 2024-02-15 |
| 2021-09-30 | -$15.88M 10-Q · filed 2022-11-03 | -$26.21M derived: sum of 2 quarters · filed 2022-11-03 | -$36.42M 10-Q · filed 2022-11-03 | -$446.01M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | -$10.33M 10-Q · filed 2022-08-09 | -$20.54M 10-Q · filed 2022-08-09 | -$430.13M derived: sum of 3 quarters · filed 2023-02-16 | -$495.38M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -$10.22M 10-Q · filed 2022-05-05 | -$419.80M derived: sum of 2 quarters · filed 2023-02-16 | -$485.05M derived: sum of 3 quarters · filed 2023-02-16 | -$524.47M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | -$409.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$474.84M derived: sum of 2 quarters · filed 2023-02-16 | -$514.26M derived: sum of 3 quarters · filed 2023-02-16 | -$534.14M 10-K · filed 2023-02-16 |
| 2020-09-30 | -$65.25M 10-Q · filed 2021-11-05 | -$104.67M derived: sum of 2 quarters · filed 2021-11-05 | -$124.56M 10-Q · filed 2021-11-05 | -$132.64M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | -$39.42M 10-Q · filed 2021-08-06 | -$59.30M 10-Q · filed 2021-08-06 | -$67.38M derived: sum of 3 quarters · filed 2022-02-18 | -$76.48M derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | -$19.88M 10-Q · filed 2021-05-07 | -$27.96M derived: sum of 2 quarters · filed 2022-02-18 | -$37.06M derived: sum of 3 quarters · filed 2022-02-18 | -$47.42M derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | -$8.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | -$17.18M derived: sum of 2 quarters · filed 2022-02-18 | -$27.54M derived: sum of 3 quarters · filed 2022-02-18 | -$30.57M 10-K · filed 2022-02-18 |
| 2019-09-30 | -$9.10M 10-Q · filed 2020-11-12 | -$19.46M derived: sum of 2 quarters · filed 2020-11-12 | -$22.49M 10-Q · filed 2020-11-12 | -$97.46M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | -$10.36M 10-Q · filed 2020-08-12 | -$13.40M 10-Q · filed 2020-08-12 | -$88.36M derived: sum of 3 quarters · filed 2021-02-26 | -$103.30M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | -$3.04M 10-Q · filed 2020-05-12 | -$78.00M derived: sum of 2 quarters · filed 2021-02-26 | -$92.93M derived: sum of 3 quarters · filed 2021-02-26 | |
| 2018-12-31 | -$74.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$89.90M derived: sum of 2 quarters · filed 2021-02-26 | -$110.76M 10-K · filed 2021-02-26 | |
| 2018-09-30 | -$14.93M 10-Q · filed 2019-11-12 | -$35.80M 10-Q · filed 2019-11-12 | ||
| 2017-12-31 | -$18.38M 10-K · filed 2020-02-27 |